NBI-18

N/A

Report date: 2025/01/26 19:16:57
NME

Base Information

Drug NameNBI-18
Drug Alias Namestem cell stimulator (NeoCytex)NBI-18
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNeuroprotectantsStem cells stimulants
TargetsUpdating
Therapy Area/IndicationsNerve DegenerationCerebrovascular Disorders
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNeoCytex Biopharma Inc
China Registration ClassN/A

Develop Information

Active CompaniesNeoCytex Biopharma Inc
Inactive CompaniesN/A
Active IndicationsNerve DegenerationCerebrovascular Disorders
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A